Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Journal of Clinical Oncology

Volumn 19, Issue 20, 2001, Pages 4058-4064

  Smith, L M ^a   Anderson, J R ^a   Qualman, S J ^a   Crist, W M ^a   Paidas, C N ^a   Teot, L A ^a   Pappo, A S ^a   Link, M P ^a   Grier, H E ^a   Wiener, E S ^a   Breneman, J C ^a   Raney, R B ^a   Maurer, H M ^a   Donaldson, S S ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; INFANT; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA;

EID: 0035886962     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.20.4058     Document Type: Article

References (21)

1. Prognosis in children with rhabdomyosarcoma: A report of the IRS studies I and II
2. Biology and therapy of pediatric rhabdomyosarcoma
3. The Intergroup Rhabdomyosarcoma Study-I: A final report
4. The Intergroup Rhabdomyosarcoma Study-II
5. The Third Intergroup Rhabdomyosarcoma Study
6. The Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease
7. Childhood rhabdomyosarcoma: Experience of the Children's Solid Tumour Group
8. Primary reexcision for patients with 'microscopic residual' tumor following initial excision of sarcomas of trunk and extremity sites
9. Prognostic factors in 951 non-metastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop
10. Lymphatic metastases with childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study
11. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study
12. Regression models and life-tables
13. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG)
14. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma
15. Genes, chromosomes, and rhabdomyosarcoma
16. Staging retroperitoneal lymph node dissection is necessary for adolescents with resected paratesticular rhabdomyosarcoma: Results of IRS-III and IRS-IV
17. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4000 cGy
18. Local tumor control in rhabdomyosarcoma following low-dose irradiation: Comparison of group II and select group III patients
19. Local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma: Prognostic factors and implications for curative therapy
20. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the International Society of Pediatric Oncology (SIOP) preliminary results
21. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: Results of the International Society of Pediatric Oncology MMT 84 study